Endovascular robotic-assisted system for cerebral angiography (ERASE): Rationale, design, and protocol of a multicenter randomized controlled trial
Neurosurgical Review · 16.11.2026 · 49 (1)
DOI: 10.1007/s10143-026-04577-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Neurosurgical Review, online erschienen am 16.11.2026. Verfasst von Yuanli Zhao und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cerebral Angiography, Endovascular Procedures, Robotic Surgical Procedures. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Beijing Medical and Health Science and Technology Promotion Center.
Abstract (Originalsprache)
Neurointerventional therapy is a cornerstone in managing head and neck vascular disorders, with cerebral angiography serving as its fundamental diagnostic and therapeutic backbone. However, manual cerebral angiography is associated with several inherent limitations. While existing robotic-assisted systems have shown promise in mitigating some of these issues, they face challenges such as limited compatibility, lengthy setup times, and a lack of high-quality real-world evidence. The ERASE trial is a multicenter, prospective, randomized controlled trial (RCT). A total of 660 eligible patients will be enrolled from seven comprehensive stroke centers in China and randomized 1:1 to either the robotic-assisted group or the control group. Both groups use the Seldinger technique for femoral/radial artery access. Operators undergo standardized training on the robotic system. The trial adopts a prospective randomized open-label blinded endpoint (PROBE) design, with all imaging endpoints adjudicated via blinded review by an independent imaging core laboratory. All patients are followed up at baseline, end of surgery, 24 h postoperatively, and 7 days post-discharge. The primary efficacy outcome is the clinical success rate. The primary safety outcome is the incidence of perioperative/postoperative complications (e.g., vascular perforation, dissection, pseudoaneurysm), serious adverse events, and device malfunctions. Secondary outcomes include technical failure rate, overall procedural time, pre-puncture setup time, mean catheterization time per target vessel, super-selective technique success rate, DSA fluoroscopy time, participant radiation dose, primary operator radiation dose, contrast agent volume and instrument performance evaluation. A key safety endpoint is the rate of new asymptomatic cerebral infarctions detected via postoperative brain MRI-diffusion-weighted imaging. As the RCT focusing on the YDHB-NS01 Ver 2.0 system, the ERASE trial addresses critical unmet needs in neurointerventional practice and will generate high-quality evidence for robotic-assisted cerebral angiography. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT07182188. TRIAL REGISTRATION DATE: 2025-09-18.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.
- Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Operating Room, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Operating Room, Beijing Tiantan Hospital, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.
Förderung
- Beijing Medical and Health Science and Technology Promotion Center
Zitieren
APA
Zhao, Y., Gui, S., Jiang, J., Zhao, Y., Liu, Q., Chang, J., Li, A., Zhang, X., Wang, F., Zhang, X., Lin, J., Jiang, Y., Liu, X., Gao, Y., Meng, X., You, W., Gong, W., Guan, S., Sun, Y., …, & Li, Y. (2026). Endovascular robotic-assisted system for cerebral angiography (ERASE): Rationale, design, and protocol of a multicenter randomized controlled trial. Neurosurgical Review, 49(1). https://doi.org/10.1007/s10143-026-04577-3
Vancouver
Zhao Y, Gui S, Jiang J, Zhao Y, Liu Q, Chang J, et al. Endovascular robotic-assisted system for cerebral angiography (ERASE): Rationale, design, and protocol of a multicenter randomized controlled trial. Neurosurgical Review. 2026;49(1). doi:10.1007/s10143-026-04577-3
BibTeX
@article{Zhao2026,
author = {Zhao, Yuanli and Gui, Siming and Jiang, Jia and Zhao, Yang and Liu, Qi and Chang, Jianbo and Li, Anqi and Zhang, Xiaobo and Wang, Fei and Zhang, Xiaoqing and Lin, Jun and Jiang, Yuhua and Liu, Xinke and Gao, Ya and Meng, Xiangyu and You, Wei and Gong, Wentao and Guan, Sheng and Sun, Yong and Meng, Xiangqi and Li, Yongli and Xu, Xiang and Li, Conghui and Li, Youxiang},
title = {Endovascular robotic-assisted system for cerebral angiography (ERASE): Rationale, design, and protocol of a multicenter randomized controlled trial},
journal = {Neurosurgical Review},
year = {2026},
volume = {49},
number = {1},
doi = {10.1007/s10143-026-04577-3}
}
EUVIMED